Resources

Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.

Roy, K.; Murtie, J. C.; El-Khodor, B. F.; Edgar, N.; Sardi, S. P.; Hooks, B. M.; Benoit-Marand, M.; Chen, C.;...

Resources

Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.

Kozikowski, A. P.; Gaisina, I. N.; Yuan, H.; Petukhov, P. A.; Blond, S. Y.; Fedolak, A.; Caldarone, B.; McGonigle, P....

Resources

Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins.

Herrera-Marschitz, M.; Bustamante, D.; Morales, P.; Goiny, M. Neurotox Res 2007, 11(3-4), 169-82.

Resources

Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection.

Kehr, J.; Hu, X.J.; Yoshitake, T.; Scheller, D. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 845, 109-113.

Resources

Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward.

Cagniard, B.; Balsam, P. D.; Brunner, D.; Zhuang, X. Neuropsychopharmacology 2006, 31, 1362-70.

Resources

Monitoring brain chemical signals by microdialysis.

Kehr, J.; Yoshitake, T. American Scientific Publishers: USA, 2006; Vol. 6.

Resources

Discovery of novel hippocampal neurogenic agents by using an in vivo stable isotope labeling technique.

Shankaran, M.; King, C.; Lee, J.; Busch, R.; Wolff, M.; Hellerstein, M. K. J Pharmacol Exp Ther 2006, 319, 1172-81.

Resources

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

Rothstein, J. D.; Patel, S.; Regan, M. R.; Haenggeli, C.; Huang, Y. H.; Bergles, D. E.; Jin, L.; Dykes Hoberg,...

Resources

Knock-in mouse models of Huntington’s disease.

Menalled, L. B. NeuroRx 2005, 2, 465-70.

Resources

Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP.

Aguirre, J.A.; Kehr, J.; Yoshitake, T.; Liu, F.L.; Rivera, A.; Fernandez-Espinola, S.; Andbjer, B.; Leo, G.; Medhurst, A.D.; Agnati, L.F.;...

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started